Molecular Therapy: Oncolytics
Elsevier · United Kingdom
eISSN2372-7705
✓ DOAJ✓ Open Access
15
/ 100
High Risk
Score Breakdown
✓ DOAJ Verified+15
Total15
Aims & Scope✦ Inferred from recent articles
Molecular Therapy: Oncolytics publishes research on engineered biologics for cancer treatment, including oncolytic viruses, engineered T cells, and antibody-drug conjugates. The journal focuses on therapies that modulate the tumor microenvironment, enhance anti-tumor immunity, and target specific cancer antigens. Studies investigate mechanisms of action, therapeutic efficacy in preclinical models, and potential clinical applications.
AI-summarised from recent articles · verify on publisher page →
General Information
Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published—
StatusActive
Total Publications—
Publisher OrgElsevier BV
Submission Info
APC Cost$3,900Above median
Peer ReviewAnonymous peer review
Review Time—
Acceptance Rate—
OA LicenseCC BY, CC BY-NC-ND
OA Rate—
Ethics & Quality
COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Think.Check.Submit Compliance
9/12 · 75%
✅
Do you know the journal / publisher?
✅
Does the journal have a website?
✅
Is the ISSN verified?
✅
Indexed in a trusted database?
✅
Peer review process documented?
❌
Follows ethical publishing standards (COPE)?
✅
APC fees clearly disclosed?
✅
Not on predatory/blacklists?
❌
Long-term digital preservation?
❌
Plagiarism detection in place?
✅
Listed in DOAJ (verified OA)?
✅
Primary language documented?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Virus-based gene therapy researchCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer-related molecular mechanisms researchMicroRNA in disease regulationViral Infectious Diseases and Gene Expression in InsectsCancer Research and TreatmentsRNA modifications and cancerRNA Interference and Gene DeliveryCircular RNAs in diseases
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref